Literature DB >> 11698614

The proteinase-activated receptor 2 is involved in nociception.

W A Hoogerwerf1, L Zou, M Shenoy, D Sun, M A Micci, H Lee-Hellmich, S Y Xiao, J H Winston, P J Pasricha.   

Abstract

The proteinase-activated receptor 2 is expressed on a subset of primary afferent neurons and may participate in the neurogenic component of inflammation. We hypothesized that this receptor may also play a role in neuronal sensitization and contribute to the pathogenesis of pain in inflammatory conditions such as pancreatitis. Using a specific proteinase-activated receptor 2 activating peptide, we found evidence of such sensitization in vitro in the form of enhanced capsaicin- and KCl-evoked release of calcitonin gene-related peptide, a marker for nociceptive signaling. We then demonstrated that injection of the proteinase-activated receptor 2 activating peptide into the pancreatic duct can activate and sensitize pancreas-specific afferent neurons in vivo, as measured by Fos expression in the dorsal horn of the spinal cord. These observations suggest that proteinase-activated receptor 2 contributes to nociceptive signaling and may provide a novel link between inflammation and pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698614      PMCID: PMC6762290     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord.

Authors:  K A Wardle; J Ranson; G J Sanger
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

3.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

4.  The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats.

Authors:  K H Kim; M G Lee; D G Kim
Journal:  Int J Pancreatol       Date:  1996-12

5.  Induction of c-fos-like protein in spinal cord neurons following sensory stimulation.

Authors:  S P Hunt; A Pini; G Evan
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

Review 6.  Inflammatory mediators of pain.

Authors:  A Dray
Journal:  Br J Anaesth       Date:  1995-08       Impact factor: 9.166

7.  Afferent innervation of the rat pancreas: retrograde tracing and immunohistochemistry in the dorsal root ganglia.

Authors:  M H Won; H S Park; Y G Jeong; H J Park
Journal:  Pancreas       Date:  1998-01       Impact factor: 3.327

8.  Peptide YY ameliorates cerulein-induced pancreatic injury in the rat.

Authors:  J M Tito; M Rudnicki; D H Jones; H D Alpern; M S Gold
Journal:  Am J Surg       Date:  1993-06       Impact factor: 2.565

9.  Purification and culture of adult rat dorsal root ganglia neurons.

Authors:  P Delree; P Leprince; J Schoenen; G Moonen
Journal:  J Neurosci Res       Date:  1989-06       Impact factor: 4.164

10.  Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade.

Authors:  C M Hingtgen; K J Waite; M R Vasko
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

View more
  42 in total

1.  Transient receptor potential ion channels V4 and A1 contribute to pancreatitis pain in mice.

Authors:  Eugene Ceppa; Fiore Cattaruzza; Victoria Lyo; Silvia Amadesi; Juan-Carlos Pelayo; Daniel P Poole; Natalya Vaksman; Wolfgang Liedtke; David M Cohen; Eileen F Grady; Nigel W Bunnett; Kimberly S Kirkwood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-10       Impact factor: 4.052

Review 2.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

3.  The pain of chronic pancreatitis: a persistent clinical challenge.

Authors:  Michael R Goulden
Journal:  Br J Pain       Date:  2013-02

Review 4.  Current understanding of the neuropathophysiology of pain in chronic pancreatitis.

Authors:  Amporn Atsawarungruangkit; Supot Pongprasobchai
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

5.  Transgastric versus laparoendoscopic single-site peritoneoscopy in a rat model: effects on motility, inflammation, and nociception.

Authors:  Jianqiang Guo; Neil P Pasricha; Mohan M Shenoy; Liansheng Liu; Kshama Mehta; Pankaj J Pasricha
Journal:  Surg Endosc       Date:  2011-10-15       Impact factor: 4.584

Review 6.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

7.  Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.

Authors:  Silvia Amadesi; Graeme S Cottrell; Lorna Divino; Kevin Chapman; Eileen F Grady; Francisco Bautista; Rustum Karanjia; Carlos Barajas-Lopez; Stephen Vanner; Nathalie Vergnolle; Nigel W Bunnett
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

8.  Protease-activated receptors as therapeutic targets in visceral pain.

Authors:  Nicolas Cenac
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

9.  Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain.

Authors:  Yi Dai; Shenglan Wang; Makoto Tominaga; Satoshi Yamamoto; Tetsuo Fukuoka; Tomohiro Higashi; Kimiko Kobayashi; Koichi Obata; Hiroki Yamanaka; Koichi Noguchi
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 10.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.